A-63162, A POTENT ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE (5-LO)

被引：0
|
作者：
CARTER, GW [1 ]
YOUNG, PR [1 ]
DYER, R [1 ]
ALBERT, DH [1 ]
BOUSKA, J [1 ]
BARLOW, J [1 ]
ROBERTS, E [1 ]
SONSALLA, J [1 ]
SUMMERS, J [1 ]
BROOKS, D [1 ]
机构：
[1] ABBOTT LABS, N CHICAGO, IL 60064 USA
来源：
FASEB JOURNAL | 1988年 / 2卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1263 / A1263
页数：1
相关论文
共 50 条
  • [31] Virtual screening, ADME study, and molecular dynamic simulation of chalcone and flavone derivatives as 5-Lipoxygenase (5-LO) inhibitor
    Mohd Amin, Siti Norhidayah
    Md Idris, Muhd Hanis
    Selvaraj, Manikandan
    Mohd Amin, Siti Norhidayu
    Jamari, Hisyam
    Kek, Teh Lay
    Salleh, Mohd Zaki
    MOLECULAR SIMULATION, 2020, 46 (06) : 487 - 496
  • [32] EFFECT OF A 5-LIPOXYGENASE (5-LO) CYCLOOXYGENASE (CO) INHIBITOR, WY-47,288, ON CUTANEOUS MODELS OF INFLAMMATION
    CARLSON, RP
    ONEILLDAVIS, L
    CALHOUN, W
    DATKO, L
    MUSSER, JH
    KREFT, AF
    CHANG, JY
    AGENTS AND ACTIONS, 1989, 26 (3-4): : 319 - 328
  • [33] A FLAVONOID, NEW POTENT 5-LIPOXYGENASE INHIBITOR
    KOHNO, SW
    TAIRA, M
    OHATA, K
    YAMAMOTO, S
    YOKOYAMA, C
    HORIE, T
    ANNALS OF ALLERGY, 1985, 55 (02): : 362 - 362
  • [34] DIPYRIDAMOLE - A POTENT AND SPECIFIC 5-LIPOXYGENASE INHIBITOR
    CARTER, GW
    DYER, R
    YOUNG, P
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 904 - 904
  • [35] 5-lipoxygenase (5-LO) in perinatal, ovine lungs: Activity in arteries versus veins.
    Ibe, BO
    Anderson, JM
    Raj, JU
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A115 - A115
  • [36] A-69412, A LONG LIVED, ORALLY ACTIVE, AND SELECTIVE 5-LIPOXYGENASE INHIBITOR
    DELLARIA, JF
    BROOKS, DW
    SUMMERS, JB
    SALLIN, KJ
    DENINNO, SL
    MARTIN, MB
    MARTIN, JG
    MOORE, JL
    HOLMS, JH
    LANNI, C
    BOUSKA, J
    YOUNG, PR
    BELL, RL
    CARTER, GW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 176 - MEDI
  • [37] AGE-RELATED INCREASES IN 5-LIPOXYGENASE (5-LO) ACTIVITY OF CATTLE ALVEOLAR MACROPHAGES
    LU, MC
    HOSTETLER, DE
    ROBINSON, NE
    DERKSEN, FJ
    PETERSGOLDEN, M
    FASEB JOURNAL, 1995, 9 (03): : A571 - A571
  • [38] WY-50,295, A SELECTIVE, ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR
    KREFT, AF
    MUSSER, JH
    KUBRAK, DM
    BANKER, AL
    MARSHALL, LA
    CARLSON, RP
    STURM, R
    HOLLOWAY, D
    BORELLA, L
    HEASLIP, R
    GRIMES, D
    WEICHMAN, B
    CHANG, JY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 151 - MEDI
  • [39] PRECLINICAL PHARMACOLOGY OF ICI-D2138, A POTENT ORALLY-ACTIVE NONREDOX INHIBITOR OF 5-LIPOXYGENASE
    MCMILLAN, RM
    SPRUCE, KE
    CRAWLEY, GC
    WALKER, ERH
    FOSTER, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) : 1042 - 1047
  • [40] DISCOVERY AND SYNTHESIS OF SB-202235, AN ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE
    ADAMS, JL
    GARIGIPATI, RS
    SORENSON, M
    ROSS, S
    SCHMIDT, SJ
    GLEASON, JG
    GRISWOLD, DE
    WEBB, EF
    BRETON, JJ
    MARSHALL, P
    HAY, D
    UNDERWOOD, D
    TORPHY, T
    NEWTON, JF
    TYRRELL, KA
    GARVER, E
    YODIS, L
    BRIAN, WR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 21 - MEDI
12345